Consolidate Medicare-certified DME providers to capture recurring rental revenue, expand referral networks, and create a scalable exit-ready platform in a highly fragmented market.
Find Home Medical Equipment Platform TargetsThe HME sector is a $55–60B highly fragmented market dominated by independent operators averaging $1M–$3M in revenue. Aging demographics, hospital-to-home care shifts, and growing respiratory and sleep therapy demand create ideal conditions for disciplined roll-up acquirers to build scaled regional platforms with durable recurring revenue.
Independent HME operators struggle with reimbursement compression, compliance costs, and succession gaps — creating motivated sellers. Consolidators benefit from shared billing infrastructure, unified payor contracting, centralized accreditation management, and referral network density that independent operators cannot achieve alone.
Minimum $2M Revenue with EBITDA Margins Above 15%
Platform companies must demonstrate sustainable profitability with enough cash flow to absorb integration costs and support SBA or institutional debt service without over-leveraging the combined entity.
Active Medicare/Medicaid Supplier Numbers and Current Accreditation
ACHC or Joint Commission accreditation in good standing with clean CMS audit history is non-negotiable. These credentials create barriers to entry and are foundational to payor contract transferability.
Diversified Product Mix Across Respiratory, Mobility, and Sleep Therapy
Platform targets should serve multiple DME categories, reducing single-product reimbursement risk and enabling cross-sell opportunities as add-on acquisitions expand the patient base.
Established Referral Relationships with Hospitals and Physician Networks
Documented referral pipelines from discharge planners, pulmonologists, and orthopedic groups are critical. Relationship ownership must extend beyond the exiting owner to ensure post-close revenue continuity.
Adjacent Service Territory with Minimal Geographic Overlap
Add-ons should expand the platform's delivery footprint into contiguous markets, increasing route density, reducing per-delivery costs, and capturing new hospital and physician referral relationships.
Complementary Product Lines or Clinical Specialties
Targets offering enteral nutrition, wound care, or pediatric DME complement core respiratory and mobility lines, broadening reimbursable services and reducing dependence on any single product category.
Minimum $1M Revenue with Recurring Rental Base Above 50%
Add-ons should generate majority recurring rental revenue rather than one-time equipment sales, ensuring predictable cash flow that supports platform-level EBITDA and exit multiple expansion.
Owner Willing to Transition for 6–12 Months Post-Close
Seller transition support is critical in HME acquisitions to protect referral relationships, transfer payor contracts, and retain key clinical staff including respiratory therapists and delivery technicians.
Build your Home Medical Equipment roll-up
DealFlow OS surfaces off-market Home Medical Equipment targets with seller signals — the foundation of every successful roll-up.
Centralized Billing and Compliance Infrastructure
Consolidating Medicare/Medicaid billing onto a single platform with dedicated compliance staff reduces audit exposure, accelerates collections, and eliminates redundant administrative overhead across acquired locations.
Payor Contract Renegotiation at Scale
A multi-location platform with expanded patient volume gains meaningful leverage to renegotiate commercial insurance reimbursement rates above what independent operators can achieve individually.
Fleet Optimization and Shared Equipment Inventory
Cross-location equipment sharing, coordinated rental fleet management, and centralized procurement from preferred suppliers reduce capital tied up in aging inventory and lower per-unit equipment costs.
Referral Network Density and Clinical Relationship Expansion
A scaled regional platform can dedicate clinical liaisons to hospital systems and physician groups, driving referral volume growth that single-location operators lack the capacity to pursue.
A well-built HME roll-up targeting 4–6 acquired locations and $8M–$15M in combined revenue with 18–22% EBITDA margins is positioned to attract regional strategic acquirers or healthcare-focused private equity at exit multiples of 6–8x EBITDA, representing meaningful multiple expansion over the 3.5–5.5x entry multiples typical in the lower middle market.
Most successful HME roll-ups achieve institutional exit readiness after 4–6 acquisitions, reaching $8M–$15M combined revenue with centralized billing, multi-state licensing, and diversified referral networks that attract strategic or PE buyers.
Medicare billing compliance is the primary risk. Acquiring a target with undisclosed recoupment exposure or audit liability can trigger platform-wide regulatory scrutiny. Pre-close billing audits and representations-and-warranties insurance are essential protections.
Yes. SBA 7(a) loans are well-suited for initial HME platform acquisitions up to $5M. Add-on acquisitions may layer SBA debt, seller notes, or PE equity depending on the platform's total leverage capacity and lender appetite.
Retain the selling owner in a transition role for 6–12 months, introduce platform clinical liaisons to key referral sources early, and ensure staff continuity for respiratory therapists and delivery technicians who maintain day-to-day hospital relationships.
More Home Medical Equipment Guides
DealFlow OS surfaces off-market platform targets with seller motivation scores. Free to join.
Find platform targets — freeNo credit card required
For Buyers
For Sellers